Global X Genomics & Biotechnology ETF
GNOM NASDAQ
The Global X Genomics & Biotechnology ETF seeks to invest in companies that potentially stand to benefit from further advances in the field of genomic science, such as companies involved in gene editing, genomic sequencing, genetic medicine/therapy, computational genomics, and biotechnology. GNOM e...
Hover to inspectDrag to measure a move← → to step through days
- Dividend yield
- 0.97% Trailing 12 months
- Volatility · 1Y
- 32.6% High Risk
- Beta
- 1.10 vs the market
- 52-week range
- 40.4572.30
How GNOM has paid off
Price return over every period, and total return with dividends reinvested, set against its benchmark.
Return by period
Price · to Oct 12Total return vs benchmark
Total Market US Cap Weighted 1200 IndexOver 1 year, GNOM returned +66.3% with dividends reinvested — +12.6 pts ahead of its benchmark.
How bumpy is the ride?
Return only means something next to the risk taken to earn it. Volatility, drawdowns and market sensitivity over 1 year.
Volatility
Annualized · 1YA typical year sees the price swing about ±33% around its trend.
Drawdown from peak
How far below its previous high the price has been Deepest fall −18.2% on Mar 30, 2026 — 67 days after the previous high
More than 5% below a high 49% of the time.
Risk vs reward
1YOver 1 year, GNOM delivered more return, with more risk than its benchmark.
Market sensitivity
BetaA beta of 1.10 means GNOM has moved more than the market.
Trend & momentum
Where the price sits against its moving averages, and how stretched the recent move is.
Price vs moving averages
Uptrend- 12-day average68.04 −2.1%
- 26-day average67.07 −0.6%
- 50-day average64.50 +3.3%
- 200-day average54.13 +23.1%
The price is above 2 of 4 averages. The 50-day average is above the 200-day, a sign of a rising longer-term trend.
Relative strength (RSI)
NeutralRSI compares recent gains with recent losses on a 0–100 scale. Above 70 a move is often considered stretched, below 30 washed out.
Technical indicators describe past prices. They are not a forecast.
What it pays you
Cash distributions over the last twelve months, and how they have grown.
About 10 USD a year for every 1,000 USD invested at today's price.
- Per share
- 0.65
- Last paid
- Jun 29, 2026
Last 12 months
0.65 USD / shareWhere GNOM shows up
Curated themes and indices that hold GNOM. Open one to see it in context, or test the whole theme in a portfolio.
About Global X Genomics & Biotechnology ETF
The Global X Genomics & Biotechnology ETF seeks to invest in companies that potentially stand to benefit from further advances in the field of genomic science, such as companies involved in gene editing, genomic sequencing, genetic medicine/therapy, computational genomics, and biotechnology. GNOM enables investors to access high growth potential through companies that are positioned to benefit from further advances in the field of genomic science.
- Featured in 1 curated theme
- Ticker
- GNOM
- Exchange
- NASDAQ
- ISIN
- US37954Y4347
- CUSIP
- 37954Y434
- Currency
- U.S. Dollar (USD)
- Country
- USA
- Sector
- Health Care
- Industry
- Research Advancement
- Benchmark
- Total Market US Cap Weighted 1200 Index
All key statistics
Details
Shareas of Oct 12, 2026
Dataas of Oct 13, 2026
Put GNOM to the test
See how it would change the return and the risk of a portfolio, with virtual money, before a single real dollar moves.
Data for information only, not investment advice. Past performance does not guarantee future results.